JAZZ Coiled Spring Ready to Release at $222.45
Neutral
Oct 9, 2026 at 2:51 AM
•
$222.45
(-3.78%)
Jazz Pharmaceuticals PLC (JAZZ) retreated 3.78%, ending the session at $222.45 on October 9.
Key indicators suggest a bearish bias:
Moving Averages
The stock trades below its 9-day EMA ($231.88) with the 21-day ($236.36) acting as overhead resistance.
Momentum
RSI at 29.4 is approaching oversold territory, which may present buying opportunities. MACD reads -4.43 against its -3.56 signal line (bearish).
Volatility
A 20-day TTM Squeeze suggests volatility is coiled and a breakout may be imminent.
Despite the bearish EMA structure, oversold RSI suggests patient buyers may find opportunity near $225.68.
Technical levels: $225.68 support, $248.69 resistance.